In colorectal cancer, PRMT3 promotes tumorigenesis through dual mechanisms whereby it stabilizes HIF1α and METTL14 in a methylation-dependent manner, thereby enhancing glycolysis, angiogenesis, and inflammation (16, 17). This evidence concerns the gene PRMT3 and colorectal cancer.